FDA Drug recall D-0651-2017
Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for W…
- FDA Drug
- Class III
- terminated
- Published 2017-04-19
On 2017-04-19 the FDA classified a Class III recall of Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for W… by West Ward Columbus, citing failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0651-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-04-04 |
| Published | 2017-04-19 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | West Ward Columbus |
| Distribution | OH |
Product
Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19
Reason
Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Identifiers
| code_info | Lot KB60707, 10/31/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0651-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.